Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Accounts Payables (2020 - 2025)

iSpecimen has reported Accounts Payables over the past 6 years, most recently at $5.4 million for Q4 2025.

  • Quarterly results put Accounts Payables at $5.4 million for Q4 2025, up 27.76% from a year ago — trailing twelve months through Dec 2025 was $5.4 million (up 27.76% YoY), and the annual figure for FY2025 was $5.4 million, up 27.76%.
  • Accounts Payables for Q4 2025 was $5.4 million at iSpecimen, up from $4.8 million in the prior quarter.
  • Over the last five years, Accounts Payables for ISPC hit a ceiling of $5.5 million in Q2 2024 and a floor of $281494.0 in Q1 2022.
  • Median Accounts Payables over the past 5 years was $3.6 million (2024), compared with a mean of $3.0 million.
  • Biggest five-year swings in Accounts Payables: crashed 86.61% in 2022 and later soared 1182.28% in 2023.
  • iSpecimen's Accounts Payables stood at $832678.0 in 2021, then surged by 195.32% to $2.5 million in 2022, then soared by 59.63% to $3.9 million in 2023, then rose by 6.93% to $4.2 million in 2024, then grew by 27.76% to $5.4 million in 2025.
  • The last three reported values for Accounts Payables were $5.4 million (Q4 2025), $4.8 million (Q3 2025), and $4.3 million (Q2 2025) per Business Quant data.